Presentation TCT 2022 TCT 736: Saline Optical Coherence Tomography (OCT) to guide revascularizationin in a patient with severe renal impairment and multivessel coronary artery disease. Presenter: George Besis September 18, 2022
Presentation TCT 2022 TCT 176: Randomized comparison of intracoronary lithotripsy and rotational atherectomy for the treatment of severely calcified vessels – ROTA.shock trial Presenter: Holger Nef September 18, 2022
Presentation TCT 2022 TCT 196: PCI versus CABG for left main disease in patients presenting with versus without an acute coronary syndrome Presenter: Prakriti Gaba September 18, 2022
Presentation TCT 2022 TCT 286: Rates of Percutaneous Coronary Revascularization in Morphological- vs Functional-Guided Arms of the INTERCLIMA (Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria Identified by OCT in Patients With ACS) Randomized… Presenter: Francesco Prati September 17, 2022
Presentation TCT 2022 TCT 649: Impossible to possible: Ecstasy to exaltation! A challenging case of percutaneous antegrade left main chronic total occlusion revascularization by novel technique of Rotablation of LAD through LM-LCX struts, finished by staged cullottes… Presenter: Sharad Chandra September 17, 2022
Presentation TCT 2022 TCT 235: 5-year prognostic value of QFR-guided revascularization in patients with stable coronary artery disease. A multicenter registry Presenter: Carlos Cortes September 17, 2022
Presentation TCT 2022 Get With the Program: Patient-Oriented Outcomes Are Key Presenter: Davide Capodanno September 17, 2022
Presentation TCT 2022 TCT 280: Combined Use of Hyperemic and Non-Hyperemic Pressure Ratios for Revascularization Decision-Making Presenter: Coen Boerhout September 17, 2022
Presentation TCT 2022 Revascularization in LV Systolic Dysfunction: Revived or Dead? Presenter: Divaka Perera September 17, 2022
Presentation TCT 2022 TCT 36: Complete revascularization versus culprit lesion only PCI in patients with diabetes mellitus and multivessel coronary artery disease: A subgroup analysis of the COMPLETE trial Presenter: Zardasht Oqab September 17, 2022
Presentation TCT 2022 TCT 35: Effects of Complete Revascularization According to Age in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel: Insights from the COMPLETE Trial Presenter: Kevin Bainey September 17, 2022
News Daily News COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK Michael O'Riordan September 15, 2022
News Conference News ESC 2022 CV Care Around Noncardiac Surgery: New ESC Guidelines Michael O'Riordan September 07, 2022
News Conference News ESC 2022 Routine Functional Testing Unnecessary After Stenting: POST-PCI Yael L. Maxwell September 06, 2022
News Conference News ESC 2022 Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE Michael O'Riordan August 31, 2022
News Conference News ESC 2022 CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2 Todd Neale August 29, 2022
News Conference News ESC 2022 P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER Todd Neale August 29, 2022
News Conference News ESC 2022 ‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR Shelley Wood August 28, 2022